Opinion
Video
Mohamad Baker Berjaoui, MD, describes benefits of Aquablation treatment in BPH
Author(s):
Key Takeaways
- Aquablation therapy shows high efficacy in reducing medication dependency and surgical retreatment rates for benign prostatic hyperplasia.
- The precision of Aquablation minimizes side effects by avoiding thermal injury, preserving sexual function, and reducing bladder neck contractures.
"I think the precision of Aquablation helps significantly with improving the results," says Mohamad Baker Berjaoui, MD.
In this video, Mohamad Baker Berjaoui, MD, discusses the BJUI Compass paper, “WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80-cm3 and 80–150-cm3 prostates.” Berjaoui is a urology resident at the University of Toronto in Ontario, Canada.
Transcription:
The study reported high rates of patients becoming medication free and avoiding surgical retreatment. Can you elaborate on the factors that likely contribute to these positive outcomes?
Again, I think the precision of Aquablation helps significantly with improving the results. There's no thermal injury with Aquablation, so that helps significantly decrease the side effects and it helps a lot with the sexual function and preserving the bladder neck and decreasing bladder neck contractures. In terms of patient selection, I think the importance of our paper is that, regardless of the patient population, the durability of the results were there, and it can be applied to prostates measuring anywhere from 30 to 150 and we're waiting for the results of the [WATER III] to see, hopefully, even bigger than 150.
This transcript was AI generated and edited by human editors for clarity.
